These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27091576)

  • 1. Postnatal knockdown of dok-7 gene expression in mice causes structural defects in neuromuscular synapses and myasthenic pathology.
    Eguchi T; Tezuka T; Miyoshi S; Yamanashi Y
    Genes Cells; 2016 Jun; 21(6):670-6. PubMed ID: 27091576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The carboxyl-terminal region of Dok-7 plays a key, but not essential, role in activation of muscle-specific receptor kinase MuSK and neuromuscular synapse formation.
    Ueta R; Tezuka T; Izawa Y; Miyoshi S; Nagatoishi S; Tsumoto K; Yamanashi Y
    J Biochem; 2017 Mar; 161(3):269-277. PubMed ID: 28069867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The MuSK activator agrin has a separate role essential for postnatal maintenance of neuromuscular synapses.
    Tezuka T; Inoue A; Hoshi T; Weatherbee SD; Burgess RW; Ueta R; Yamanashi Y
    Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16556-61. PubMed ID: 25368159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations causing DOK7 congenital myasthenia ablate functional motifs in Dok-7.
    Hamuro J; Higuchi O; Okada K; Ueno M; Iemura S; Natsume T; Spearman H; Beeson D; Yamanashi Y
    J Biol Chem; 2008 Feb; 283(9):5518-24. PubMed ID: 18165682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular mechanisms underlying the formation and maintenance of neuromuscular junctions and a possible therapeutic approach.].
    Eguchi T; Tezuka T; Miyoshi S; Yamanashi Y
    Clin Calcium; 2017; 27(3):413-419. PubMed ID: 28232656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dok-7/MuSK signaling and a congenital myasthenic syndrome.
    Yamanashi Y; Higuch O; Beeson D
    Acta Myol; 2008 Jul; 27(1):25-9. PubMed ID: 19108574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of Dok-7 in skeletal muscle enhances neuromuscular transmission with structural alterations of neuromuscular junctions: Implications in robustness of neuromuscular transmission.
    Eguchi T; Tezuka T; Fukudome T; Watanabe Y; Sagara H; Yamanashi Y
    Biochem Biophys Res Commun; 2020 Feb; 523(1):214-219. PubMed ID: 31848047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dok-7 activates the muscle receptor kinase MuSK and shapes synapse formation.
    Inoue A; Setoguchi K; Matsubara Y; Okada K; Sato N; Iwakura Y; Higuchi O; Yamanashi Y
    Sci Signal; 2009 Feb; 2(59):ra7. PubMed ID: 19244212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromuscular disease. DOK7 gene therapy benefits mouse models of diseases characterized by defects in the neuromuscular junction.
    Arimura S; Okada T; Tezuka T; Chiyo T; Kasahara Y; Yoshimura T; Motomura M; Yoshida N; Beeson D; Takeda S; Yamanashi Y
    Science; 2014 Sep; 345(6203):1505-8. PubMed ID: 25237101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dok-7 promotes slow muscle integrity as well as neuromuscular junction formation in a zebrafish model of congenital myasthenic syndromes.
    Müller JS; Jepson CD; Laval SH; Bushby K; Straub V; Lochmüller H
    Hum Mol Genet; 2010 May; 19(9):1726-40. PubMed ID: 20147321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transcription factor Sp1 plays a crucial role in dok-7 gene expression.
    Hamuro J; Hishida Y; Higuchi O; Yamanashi Y
    Biochem Biophys Res Commun; 2011 May; 408(2):293-9. PubMed ID: 21504746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular mechanisms underlying the formation of neuromuscular junction].
    Higuchi O; Yamanashi Y
    Brain Nerve; 2011 Jul; 63(7):649-55. PubMed ID: 21747134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific binding of collagen Q to the neuromuscular junction is exploited to cure congenital myasthenia and to explore bases of myasthenia gravis.
    Ohno K; Ito M; Kawakami Y; Krejci E; Engel AG
    Chem Biol Interact; 2013 Mar; 203(1):335-40. PubMed ID: 22981737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Overview: MuSK/Dok-7].
    Motomura M; Fukuda T; Yoshimura T; Tsujihata M
    Nihon Rinsho; 2008 Jun; 66(6):1140-8. PubMed ID: 18540360
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Miyoshi S; Tezuka T; Arimura S; Tomono T; Okada T; Yamanashi Y
    EMBO Mol Med; 2017 Jul; 9(7):880-889. PubMed ID: 28490573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dok-7 regulates neuromuscular synapse formation by recruiting Crk and Crk-L.
    Hallock PT; Xu CF; Park TJ; Neubert TA; Curran T; Burden SJ
    Genes Dev; 2010 Nov; 24(21):2451-61. PubMed ID: 21041412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MuSK levels differ between adult skeletal muscles and influence postsynaptic plasticity.
    Punga AR; Maj M; Lin S; Meinen S; Rüegg MA
    Eur J Neurosci; 2011 Mar; 33(5):890-8. PubMed ID: 21255125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The muscle protein Dok-7 is essential for neuromuscular synaptogenesis.
    Okada K; Inoue A; Okada M; Murata Y; Kakuta S; Jigami T; Kubo S; Shiraishi H; Eguchi K; Motomura M; Akiyama T; Iwakura Y; Higuchi O; Yamanashi Y
    Science; 2006 Jun; 312(5781):1802-5. PubMed ID: 16794080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of salbutamol on neuromuscular junction function and structure in a mouse model of DOK7 congenital myasthenia.
    Webster RG; Vanhaesebrouck AE; Maxwell SE; Cossins JA; Liu W; Ueta R; Yamanashi Y; Beeson DMW
    Hum Mol Genet; 2020 Aug; 29(14):2325-2336. PubMed ID: 32543656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesdc2 plays a key role in cell-surface expression of Lrp4 and postsynaptic specialization in myotubes.
    Hoshi T; Tezuka T; Yokoyama K; Iemura S; Natsume T; Yamanashi Y
    FEBS Lett; 2013 Nov; 587(23):3749-54. PubMed ID: 24140340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.